Gary W. Hunninghake

34.8k total citations · 9 hit papers
273 papers, 24.9k citations indexed

About

Gary W. Hunninghake is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Gary W. Hunninghake has authored 273 papers receiving a total of 24.9k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Pulmonary and Respiratory Medicine, 79 papers in Physiology and 75 papers in Immunology. Recurrent topics in Gary W. Hunninghake's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (95 papers), Sarcoidosis and Beryllium Toxicity Research (36 papers) and Immune Response and Inflammation (36 papers). Gary W. Hunninghake is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (95 papers), Sarcoidosis and Beryllium Toxicity Research (36 papers) and Immune Response and Inflammation (36 papers). Gary W. Hunninghake collaborates with scholars based in United States, Australia and United Kingdom. Gary W. Hunninghake's co-authors include Martha M. Monick, Ronald G. Crystal, James E. Gadek, M. M. Monick, Thomas Groß, Ulrich Costabel, Linda S. Powers, Anthony S. Fauci, Oichi Kawanami and Jack D. Fulmer and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary W. Hunninghake

268 papers receiving 23.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

2001 1.2k citations Robert P. Baughman, Alvin S. Teirstein et al. American Journal of Respiratory and Critical Care Medicine profile →
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

1999 1.0k citations Gary W. Hunninghake et al. PubMed profile →
Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

1979 808 citations Gary W. Hunninghake, Ronald G. Crystal et al. PubMed profile →
Idiopathic Pulmonary Fibrosis

2001 791 citations Gary W. Hunninghake et al. profile →
ATS/ERS/WASOG statement on sarcoidosis

1999 589 citations Gary W. Hunninghake et al. profile →
Pulmonary Sarcoidosis

1981 553 citations Gary W. Hunninghake, Ronald G. Crystal profile →
Interstitial lung disease: Current concepts of pathogenesis, staging and therapy

1981 424 citations Ronald G. Crystal, Bruce R. Line et al. profile →
Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.

1979 418 citations Gary W. Hunninghake, Ronald G. Crystal et al. PubMed profile →
Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers.

1983 375 citations Gary W. Hunninghake et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary W. Hunninghake United States	82	13.4k	8.7k	4.7k	4.6k	4.0k	273	24.9k
David A. Schwartz United States	80	11.0k 0.8×	4.8k 0.6×	6.0k 1.3×	4.1k 0.9×	3.0k 0.8×	317	22.9k
Moisés Selman Mexico	81	19.4k 1.4×	4.3k 0.5×	2.3k 0.5×	4.8k 1.0×	2.4k 0.6×	341	26.1k
Friedrich Grimminger Germany	90	18.5k 1.4×	5.7k 0.7×	3.4k 0.7×	7.2k 1.6×	2.2k 0.5×	556	31.3k
Jack A. Elias United States	88	8.7k 0.7×	8.6k 1.0×	9.7k 2.1×	8.5k 1.9×	2.5k 0.6×	300	27.9k
Jack Gauldie Canada	95	9.1k 0.7×	4.1k 0.5×	9.1k 1.9×	8.2k 1.8×	3.3k 0.8×	416	31.9k
Robert Homer United States	72	7.9k 0.6×	5.7k 0.7×	7.0k 1.5×	5.6k 1.2×	1.7k 0.4×	203	21.2k
Erwin W. Gelfand United States	86	4.5k 0.3×	9.2k 1.1×	11.8k 2.5×	6.8k 1.5×	3.0k 0.8×	610	27.3k
Rubin M. Tuder United States	98	20.6k 1.5×	5.0k 0.6×	3.6k 0.8×	9.7k 2.1×	3.2k 0.8×	330	33.1k
Cory M. Hogaboam United States	78	6.7k 0.5×	3.5k 0.4×	6.9k 1.5×	3.9k 0.8×	2.7k 0.7×	322	18.9k
Marc Peters‐Golden United States	72	4.7k 0.4×	4.6k 0.5×	4.7k 1.0×	4.9k 1.1×	1.8k 0.4×	274	17.3k

Countries citing papers authored by Gary W. Hunninghake

Since Specialization

Citations

This map shows the geographic impact of Gary W. Hunninghake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Hunninghake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Hunninghake more than expected).

Fields of papers citing papers by Gary W. Hunninghake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Hunninghake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Hunninghake. The network helps show where Gary W. Hunninghake may publish in the future.

Co-authorship network of co-authors of Gary W. Hunninghake

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Hunninghake. A scholar is included among the top collaborators of Gary W. Hunninghake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Hunninghake. Gary W. Hunninghake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunninghake, Gary W., et al.. (2015). Current Concepts of the Pathogenesis of Sarcoidosis1,2. American Review of Respiratory Disease. 10 indexed citations

Hunninghake, Gary W. & Ronald G. Crystal. (2015). Cigarette Smoking and Lung Destruction. American Review of Respiratory Disease.

Keogh, Brendan A., Gary W. Hunninghake, Bruce R. Line, & Ronald G. Crystal. (2015). The Alveolitis of Pulmonary Sarcoidosis. American Review of Respiratory Disease.

Hunninghake, Gary W., Kevin C. Doerschug, Amanda Nymon, et al.. (2010). Insulin-like Growth Factor–1 Levels Contribute to the Development of Bacterial Translocation in Sepsis. American Journal of Respiratory and Critical Care Medicine. 182(4). 517–525. 49 indexed citations

Ashare, Alix, Amanda Nymon, Kevin C. Doerschug, et al.. (2008). Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance. American Journal of Respiratory and Critical Care Medicine. 178(2). 149–157. 36 indexed citations

Nyunoya, Toru, Martha M. Monick, Aloysius J. Klingelhutz, et al.. (2008). Cigarette Smoke Induces Cellular Senescence via Werner's Syndrome Protein Down-regulation. American Journal of Respiratory and Critical Care Medicine. 179(4). 279–287. 65 indexed citations

Baran, Christopher P., Judy M. Opalek, Christie A. Newland, et al.. (2007). Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 176(1). 78–89. 153 indexed citations

Baughman, Robert P., Alvin S. Teirstein, Marc A. Judson, et al.. (2001). Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 164(10). 1885–1889. 1186 indexed citations breakdown →

Hunninghake, Gary W., M. Bridget Zimmerman, David A. Schwartz, et al.. (2001). Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 164(2). 193–196. 372 indexed citations

10.

Uppaluri, Renuka, Eric A. Hoffman, Milan Sonka, et al.. (1999). Computer Recognition of Regional Lung Disease Patterns. American Journal of Respiratory and Critical Care Medicine. 160(2). 648–654. 179 indexed citations

11.

Kline, Joel N., John D. Cowden, Gary W. Hunninghake, et al.. (1999). Variable Airway Responsiveness to Inhaled Lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine. 160(1). 297–303. 185 indexed citations

12.

Mason, Robert J., et al.. (1999). Pharmacological Therapy for Idiopathic Pulmonary Fibrosis: Past, Present, and Future. American Journal of Respiratory and Critical Care Medicine. 160(5). 1771–1777. 103 indexed citations

13.

Uppaluri, Renuka, Eric A. Hoffman, Milan Sonka, Gary W. Hunninghake, & Geoffrey McLennan. (1999). Interstitial Lung Disease: A Quantitative Study Using the Adaptive Multiple Feature Method. American Journal of Respiratory and Critical Care Medicine. 159(2). 519–525. 417 indexed citations

14.

Ward, Peter A. & Gary W. Hunninghake. (1998). Lung Inflammation and Fibrosis. American Journal of Respiratory and Critical Care Medicine. 157(4). S123–S129. 185 indexed citations

15.

Geist, Lois J. & Gary W. Hunninghake. (1993). Potential Role of Viruses in the Pathogenesis of Pulmonary Fibrosis. CHEST Journal. 103(2). 119S–120S. 10 indexed citations

16.

Mallampalli, Rama K. & Gary W. Hunninghake. (1993). Expression of Immunoreactive Cytidine 5′-Triphosphate: Cholinephosphate Cytidylyltransferase in Developing Rat Lung. Pediatric Research. 34(4). 502–510. 13 indexed citations

17.

Schwartz, David A., et al.. (1993). Restrictive lung function and asbestos-induced pleural fibrosis. A quantitative approach.. Journal of Clinical Investigation. 91(6). 2685–2692. 34 indexed citations

18.

Hunninghake, Gary W., Brian G. Monks, Lois J. Geist, et al.. (1992). The Functional Importance of a Cap Site-Proximal Region of the Human Prointerleukin 1β Gene Is Defined by Viral Protein trans -Activation. Molecular and Cellular Biology. 12(8). 3439–3448. 19 indexed citations

19.

Goldsmith, Jonathan C., et al.. (1983). IMMUNOLOGIC PROFILES OF ADULTS WITH CONGENITAL BLEEDING DISORDERS. PubMed. 1(3). 163–179.

20.

Hunninghake, Gary W., John I. Gallin, & A S Fauci. (1978). Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 117(1). 15–23. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact